[go: up one dir, main page]

NO20064902L - Imidazopyridinforbindelse - Google Patents

Imidazopyridinforbindelse

Info

Publication number
NO20064902L
NO20064902L NO20064902A NO20064902A NO20064902L NO 20064902 L NO20064902 L NO 20064902L NO 20064902 A NO20064902 A NO 20064902A NO 20064902 A NO20064902 A NO 20064902A NO 20064902 L NO20064902 L NO 20064902L
Authority
NO
Norway
Prior art keywords
alkyl group
substituted
hydrogen atom
group
compound
Prior art date
Application number
NO20064902A
Other languages
English (en)
Inventor
Shuhei Miyazawa
Hitoshi Harada
Hideaki Fujisaki
Atsuhiko Kubota
Kotaro Kodama
Junichi Nagakawa
Nobuhisa Watanabe
Kiyoshi Oketani
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of NO20064902L publication Critical patent/NO20064902L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En forbindelse representert ved følgende generelle formel (1) eller et salt eller et hydrat derav: hvori R1 representerer en C1-C6 alkylgruppe eller C2-C6 alkynylgruppe, hvilket kan være substituert eller en fenylgruppe hvilket kan være substituert, R2 representerer et hydrogenatom eller en C1-C6 alkylgruppe, R3 representerer metyl- eller etylgruppe, R4 representerer en C1-C6 alkylgruppe, R5 representerer et hydrogenatom, tilveiebringer en forbindelse hvori R1 er C1-C6 alkylgruppe usubstituert eller substituert med et halogenatom og R2 er ekskludert med et hydrogenatom.
NO20064902A 2004-04-22 2006-10-26 Imidazopyridinforbindelse NO20064902L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004126533 2004-04-22
PCT/JP2005/008311 WO2005103049A1 (en) 2004-04-22 2005-04-21 Imidazopyridine compound

Publications (1)

Publication Number Publication Date
NO20064902L true NO20064902L (no) 2006-12-04

Family

ID=35196916

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064902A NO20064902L (no) 2004-04-22 2006-10-26 Imidazopyridinforbindelse

Country Status (17)

Country Link
US (2) US20050272764A1 (no)
EP (1) EP1737862A4 (no)
JP (1) JP4749335B2 (no)
KR (1) KR20070007149A (no)
CN (1) CN1976929A (no)
AU (1) AU2005235906A1 (no)
BR (1) BRPI0509986A (no)
CA (1) CA2562812A1 (no)
IL (1) IL178774A0 (no)
MX (1) MXPA06011993A (no)
NO (1) NO20064902L (no)
NZ (1) NZ550624A (no)
RU (1) RU2373206C2 (no)
SG (1) SG151251A1 (no)
TW (1) TW200606163A (no)
WO (1) WO2005103049A1 (no)
ZA (1) ZA200608769B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2008047853A1 (ja) * 2006-10-19 2010-02-25 味の素株式会社 胃食道逆流症の予防・治療剤
CN101492464B (zh) * 2008-01-25 2011-01-12 山东轩竹医药科技有限公司 含有二氧杂环庚烷并吡啶的巯基咪唑并吡啶衍生物
CN101492452B (zh) * 2008-01-25 2010-11-17 山东轩竹医药科技有限公司 含有二氧杂环庚烷并吡啶的巯基苯并咪唑衍生物
CN101497622B (zh) * 2008-01-30 2011-04-27 山东轩竹医药科技有限公司 吡啶甲基亚磺酰基咪唑并吡啶衍生物
WO2013011932A1 (ja) * 2011-07-15 2013-01-24 塩野義製薬株式会社 Ａｍｐｋ活性化作用を有するアザベンズイミダゾール誘導体

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
DK585485A (da) 1984-12-18 1986-08-08 Utsuka Pharm Co Ltd Tetrahydroquinolinderivat, imidazopyridinderivat, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat med mindst en saadan forbindelse
JPS62207271A (ja) 1986-03-06 1987-09-11 Yamanouchi Pharmaceut Co Ltd ２−ピリジルメチルチオ基または２−ピリジルメチルスルフイニル基で置換された縮合環化合物
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
JPH0222273A (ja) 1987-07-21 1990-01-25 Yoshitomi Pharmaceut Ind Ltd ピリジン化合物およびその医薬用途
JPH0633261B2 (ja) 1988-01-22 1994-05-02 東京田辺製薬株式会社 新規なイミダゾ［４，５−ｂピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
JPH06507133A (ja) 1990-05-18 1994-08-11 ツェットエフ、フリードリッヒスハーフェン、アクチエンゲゼルシャフト 液圧設備における振動減衰装置
CA2083606C (en) * 1990-06-20 2001-08-21 Arne Elof Brandstrom Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
JPH05117268A (ja) 1991-10-22 1993-05-14 Yoshitomi Pharmaceut Ind Ltd ピリジン化合物
EP0764160A1 (de) * 1994-06-10 1997-03-26 Byk Gulden Lomberg Chemische Fabrik GmbH Thiopyridine zur bekämpfung von helicobacter-bakterien
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
EP1154771A4 (en) 1999-02-26 2005-04-20 Nitromed Inc INHIBITORS OF THE PROTON NITROSIS AND NITROSYL PUMP, COMPOSITIONS AND METHODS OF USE
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation

Also Published As

Publication number Publication date
US20050272764A1 (en) 2005-12-08
US20060167041A1 (en) 2006-07-27
BRPI0509986A (pt) 2007-10-16
TW200606163A (en) 2006-02-16
KR20070007149A (ko) 2007-01-12
RU2006141255A (ru) 2008-05-27
JP2007533630A (ja) 2007-11-22
US7781452B2 (en) 2010-08-24
EP1737862A1 (en) 2007-01-03
WO2005103049A1 (en) 2005-11-03
ZA200608769B (en) 2008-06-25
RU2373206C2 (ru) 2009-11-20
AU2005235906A1 (en) 2005-11-03
CN1976929A (zh) 2007-06-06
JP4749335B2 (ja) 2011-08-17
IL178774A0 (en) 2007-02-11
NZ550624A (en) 2009-08-28
MXPA06011993A (es) 2007-04-24
SG151251A1 (en) 2009-04-30
CA2562812A1 (en) 2005-11-03
EP1737862A4 (en) 2007-11-28

Similar Documents

Publication Publication Date Title
NO20074763L (no) (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi
MX2010001773A (es) Metodo para preparar derivados de 5-haloalquil-4,5-dihidroisoxasol .
EP1338595A3 (en) Xanthine derivatives as DPP-IV inhibitors
TW200619207A (en) HDAC inhibitor
WO2009156861A8 (en) Substituted pyrimidone derivatives
CA2494047A1 (en) Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles
WO2005037781A3 (fr) Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
DE602004032431D1 (de) Pyrimidin-verbindungen und diese enthaltende zusammensetzungen zur schädlingsbekämpfung
MX2009004920A (es) Nuevos derivados de aminopirimidina como inhibidores de plk1.
ATE388146T1 (de) 1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor
WO2008136444A1 (ja) 縮合複素環誘導体
NO20074311L (no) Kinazolinderivat med tyrosinkinase-inhiberendeaktivitet
NO331165B1 (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
MX2008016558A (es) Preparacion y aplicacion terapéutica de derivados de 2-benzoil-imidazopiridinas.
TNSN07439A1 (en) Derivatives of,4,5 - diarylpyrrole, preparation method thereof and use of same in therapeutics
TW200517387A (en) Compounds exhibiting thrombopoietin receptor agonism
NO20053449L (no) 3-substituerte 4-pyrimidonderivater
NO20064902L (no) Imidazopyridinforbindelse
TW200607808A (en) Pyrido-pyrimidine derivatives, preparation thereof and application thereof
TNSN08161A1 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
GB0326964D0 (en) Chemical compounds
ATE445619T1 (de) Pyridinylpyrazolopyrimidinon-derivate als pde 7 inhibitoren
NO20074738L (no) Aktivator for peroksisom-proliferator som aktiverer reseptor delta
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
ATE399169T1 (de) Imidazopyridinderivate als inhibitoren der induzierbaren no-synthase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application